BioTissue - Crunchbase Company Profile & Funding

Q: Where is BioTissue's headquarters?

BioTissue is located in Miami, Florida, United States.

Q: Who invested in BioTissue?

BioTissue has 3 investors including Essex Woodlands Healthcare Partners And Ballast Point Ventures.

Q: When was the last funding round for BioTissue?

BioTissue closed its last funding round on obfuscated from a Series C round.

Q: How much funding has BioTissue raised to date?

BioTissue has raised obfuscated.

Overview

BioTissue

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About BioTissue

CB Rank

14180

BioTissue offers regenerative amniotic tissue-based products for ophthalmology, optometry, musculoskeletal, and wound care markets.

Founded

obfuscation

Private

Series C

Miami, Florida, United States

251-500

biotissue.com/

Biotechnology

Health Care

Medical

Medical Device

Pharmaceutical

Therapeutics

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Amy H. Tseng: Founder and Board Member
Past Role: BioTissue, President, CEO & Founder
Michael Cornelius: Chief Financial Officer

Details

Legal Name

BioTissue , Inc.

Also Known As

Tissuetech

Operating Status

Active

Company Type

For Profit

Founders

Amy H. Tseng, Scheffer C.G. Tseng

About the Company

BioTissue is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and umbilical cord-based products, thereby enabling physicians to avail of enhanced regenerative healing technology in eye care, wound care, and orthopedics.

Tissuetech

was founded in 2001 and is headquartered in Miami, Florida.

Phone Number

+1 786-817-6690

Contact Email

info@tissuetech.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

BioTissue is

Lorem

to be growing

Top Contributing Factors

Operations Contraction

Growth Prediction

See this Growth Prediction

Products & Services

Clarix 1K

A cryopreserved ultra-thick human birth tissue allograft used as an adjunct in urological surgeries to support healing by managing inflammation and adhesion formation.

Prokera

A biologic corneal bandage device using cryopreserved amniotic membrane to treat ocular surface diseases by reducing inflammation and promoting healing.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C
obfuscated obfuscation	Series C - BioTissue	2	obfuscated obfuscation	Essex Woodlands Healthcare Partners	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Essex Woodlands Healthcare Partners	Yes	Series C - BioTissue	Marty Sutter, William A. Hawkins
Essex Woodlands Healthcare Partners	Yes	Series C - BioTissue	Marty Sutter, William A. Hawkins
Essex Woodlands Healthcare Partners	Yes	Series C - BioTissue	Marty Sutter, William A. Hawkins
Essex Woodlands Healthcare Partners	Yes	Series C - BioTissue	Marty Sutter, William A. Hawkins
Essex Woodlands Healthcare Partners	Yes	Series C - BioTissue	Marty Sutter, William A. Hawkins